We are live on
!
Find out more
iBio
IBIO
IBIO
13 hedge funds and large institutions have $184K invested in iBio in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 13 → 13 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
33% less capital invested
Capital invested by funds: $275K → $184K (-$91K)
Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$20.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.87K |
| 3 |
VF
Virtu Financial
New York
|
+$774 |
| 4 |
BlackRock
New York
|
+$387 |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$49.5K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$16K |
| 3 |
S
SignatureFD
Atlanta,
Georgia
|
-$13K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$5.42K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$2.71K |
